111, Inc. Sponsored ADR (NASDAQ:YI) Sees Large Decrease in Short Interest

111, Inc. Sponsored ADR (NASDAQ:YI) was the recipient of a large decrease in short interest during the month of December. As of December 15th, there was short interest totaling 1,000 shares, a decrease of 31.9% from the November 30th total of 1,469 shares. Based on an average daily volume of 11,810 shares, the short-interest ratio is currently 0.1 days. Currently, 0.0% of the shares of the stock are sold short. Currently, 0.0% of the shares of the stock are sold short. Based on an average daily volume of 11,810 shares, the short-interest ratio is currently 0.1 days.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of 111 in a research note on Monday, December 22nd. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat, the company has a consensus rating of “Sell”.

111 Stock Down 0.3%

Shares of NASDAQ YI opened at $3.08 on Monday. The firm has a 50-day simple moving average of $3.88 and a 200-day simple moving average of $5.55. The stock has a market capitalization of $26.61 million, a price-to-earnings ratio of -3.67 and a beta of 0.48. 111 has a 52 week low of $2.80 and a 52 week high of $11.35.

111 (NASDAQ:YI) last posted its quarterly earnings results on Wednesday, December 17th. The company reported ($1.20) earnings per share for the quarter. The company had revenue of $421.49 million for the quarter.

About 111

111, Inc (NASDAQ: YI) is a leading online pharmacy e-commerce platform in China, operating under the brand 111.com. The company provides consumers with a comprehensive selection of pharmaceutical and healthcare products through its proprietary digital channels, including a website and mobile applications. By integrating online ordering, prescription management, and direct-to-consumer delivery, 111, Inc aims to streamline the purchase of medicines and health-related goods for customers nationwide.

111, Inc’s product portfolio encompasses prescription and over-the-counter drugs, nutritional supplements, vitamins, maternal and child care items, personal care products, and beauty goods.